ResMed Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+11.0% +$141M
$1.42B
Cost of Revenue↑+2.5% +$13M
$544M
Gross Profit↑+17.0% +$127M
$879M
R&D↑+11.8% +$10M
$91M
SG&A↑+15.2% +$37M
$278M
D&A↑+7.4% +$3M
$50M
Operating Income↑+17.8% +$74M
$492M
EBITDA↑+16.8% +$78M
$542M
Interest Expense↑+1125.7% +$9M
$8M
Interest Income
—
Other Income/Expense↑+3991.1% +$12M
$12M
Pretax Income↑+18.6% +$78M
$496M
Tax Provision↑+40.5% +$30M
$104M
Net Income↑+13.9% +$48M
$393M
Gross Margin↑+3.2pts
61.8%
Operating Margin↑+2.0pts
34.6%
Net Margin↑+0.7pts
27.6%
Effective Tax Rate↑+3.3pts
20.9%
Deferred Tax Liabilities
—
ETR Federal Statutory
—
Operating Lease Cost↓-8.5% -$2M
$19M
Revenue YoY Variation↑+0.7pts
11.0%
Income YoY Variation↓-33.8pts
17.8%
Revenue QoQ Variation↑+1.8pts
6.5%
Income QoQ Variation↑+2.4pts
10.1%